Flutazolam
Clinical data | |
---|---|
Trade names | Coreminal (JP) |
Other names | 13-chloro- 2-(2-fluorophenyl)- 9-(2-hydroxyethyl)- 3-oxa- 6,9-diazatricyclo[8.4.0.02,6] tetradeca-1(10),11,13- trien- 8-one |
AHFS/Drugs.com | International Drug Names |
Routes of administration | Oral |
Legal status | |
Legal status |
|
Pharmacokinetic data | |
Metabolism | Hepatic |
Elimination half-life | 3.5 hours (parent compound); 47-100 hours (major metabolite) |
Identifiers | |
| |
JSmol) | |
| |
| |
(what is this?) (verify) |
Flutazolamdesalkylflurazepam, also known as norflurazepam, which is also a principal metabolite of flurazepam (trade name Dalmane).[3] While flutazolam has a very short half-life of only 3.5 hours, n-desalkylflurazepam has a long half-life of between 47–100 hours.[4]
Flutazolam is closely related in structure to another benzodiazepine, haloxazolam.[5][6]
See also
- Benzodiazepine
- Flurazepam
- N-desalkylflurazepam
References
- ^ DE 1952486
- ^ Mitsushima T, Ueki S. Psychopharmacological effects of flutazolam (MS-4101). Nippon Yakurigaku Zasshi. 1978 Nov;74(8):959-79. (Japanese).
- PMID 15869852.
- ^ "Dalmane Prescribing Information" (PDF). Prescribing Information for Dalmane. FDA. Retrieved 3 April 2022.
- PMID 2870816.
- PMID 2894449.